Back to all news
New Report Highlights Clinical AI Performance, Sustainability, and Adoption Challenges
A multi-institutional review details key challenges, progress, and sustainability concerns in deploying clinical AI in real-world healthcare settings.
Key Details
- 1ARISE network (Stanford, Harvard, Virginia, Minnesota) reviewed high-impact 2025 clinical AI studies.
- 2Real-world impact lags behind model capabilities, with few studies demonstrating measurable outcomes.
- 3Frontier LLMs excel in reasoning but struggle with uncertainty or context change.
- 4Clinicians value workflow automation, but key target use cases are understudied.
- 5FDA clearance for AI is increasing, but narrow, domain-specific tools are most likely to gain adoption.
- 6Sustainability concerns rise; AI models and data centers contribute significant carbon emissions.
Why It Matters
This review provides evidence-based guidance for translating AI advances from research to practice, underscoring the importance of rigorous standards, transparency, and sustainability. Imaging AI professionals should note the trend toward regulatory approvals and practical clinical impact, as well as institutional responsibility for environmental considerations.
Source
HealthExec
Related News
•AuntMinnie
Study: Computer Vision Models Best LLMs in Chest CT Breast Abnormality Detection
Computer vision models (CVMs) surpass large language models (LLMs) in accurately labeling incidental breast abnormalities on chest CT scans.
•Cardiovascular Business
Radiology Maintains Lead in FDA-Cleared AI Algorithms, Cardiology Follows
Radiology remains the top specialty for FDA-cleared AI, with cardiology as a strong second, particularly in cardiovascular imaging.
•AuntMinnie
Deep Learning Models Rival Radiologists for Pancreatic Cancer Detection on CT
Deep-learning models achieved comparable or superior accuracy to experienced radiologists in detecting pancreatic cancer on CT scans, especially for small tumors.